ADIL Adial Pharmaceuticals Inc

Adial Pharmaceuticals Inc is a United States-based pharmaceutical company. The company develops prescription medications for addiction and related disorders.

Their auditors issued a going concern opinion on their December 31, 2019 financial statements, expressing substantial doubt that they could continue as an ongoing business for the next twelve months.   

$2.64  -0.03 (-1.12%)
As of 12/06/2021 16:00:00 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  07/27/2018
Outstanding shares:  20,766,712
Average volume:  286,174
Market cap:   $55,447,121
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    00688A106
ISIN:        US00688A1060
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   7.50
PS ratio:   0.00
Return on equity:   -236.97%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy